Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. read more
Apellis Pharmaceuticals Meetings Score
Apellis Pharmaceuticals Meetings Score
Get insights into the Meetings Score of Apellis Pharmaceuticals on Comparably. See Meetings Score by Department, Gender, Ethnicity and more.
Where This Score Ranks Apellis Pharmaceuticals' Meetings
- ?
Not enough ratings to compare against similar size companies on Comparably.
- 4th
4th place versus 3 competitors rated on Comparably
?
Not Enough Ratings to Display
Rate Your ExperienceNot Enough Ratings To Show Who Ranks Meetings the Highest
Anonymously rate my experience at Apellis PharmaceuticalsNot Enough Ratings To Show Who Ranks Meetings the Lowest
Anonymously rate my experience at Apellis PharmaceuticalsApellis Pharmaceuticals Meetings At a Glance
2 employees at Apellis Pharmaceuticals left 2 ratings about their company meetings. This category rates how employees feel about the quality, frequency, and effectiveness of the meetings they have to take part in every week.
Compared with their competitors Biogen, MyoKardia, and Reata Pharmaceuticals, they rank 4th.
Apellis Pharmaceuticals' rank score for Meetings over the last 90 days has remained steady at 55/100.
Apellis Pharmaceuticals' Meetings Trendline
- Apellis Pharmaceuticals55
- Similar Size on Comparably
How Apellis Pharmaceuticals' Meetings Score is Calculated
Are your company's meetings effective?
How would you rate the value & quality of meetings at your company?
Apellis Pharmaceuticals' Meetings Rank Against Similar Sized Companies on Comparably
?
Not enough ratings to compare against similar size companies on Comparably.
Not Enough Ratings To Rank Against Similar Sized Companies on Comparably
Anonymously rate my experience at Apellis PharmaceuticalsAnonymously Ask Apellis Pharmaceuticals Any Question
Are You an Employee at Apellis Pharmaceuticals?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Apellis Pharmaceuticals
×